BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 17341467)

  • 1. A non-covalent peptide-based carrier for in vivo delivery of DNA mimics.
    Morris MC; Gros E; Aldrian-Herrada G; Choob M; Archdeacon J; Heitz F; Divita G
    Nucleic Acids Res; 2007; 35(7):e49. PubMed ID: 17341467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A non-covalent peptide-based strategy for ex vivo and in vivo oligonucleotide delivery.
    Crombez L; Morris MC; Heitz F; Divita G
    Methods Mol Biol; 2011; 764():59-73. PubMed ID: 21748633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular delivery of peptide nucleic acid by cell-penetrating peptides.
    Kilk K; Langel U
    Methods Mol Biol; 2005; 298():131-41. PubMed ID: 16044544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of a new generation of PNAs with a peptide-based carrier enables efficient targeting of cell cycle progression.
    Morris MC; Chaloin L; Choob M; Archdeacon J; Heitz F; Divita G
    Gene Ther; 2004 May; 11(9):757-64. PubMed ID: 14961071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved cellular uptake of antisense peptide nucleic acids by conjugation to a cell-penetrating peptide and a lipid domain.
    Shiraishi T; Nielsen PE
    Methods Mol Biol; 2011; 751():209-21. PubMed ID: 21674333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting cyclin B1 through peptide-based delivery of siRNA prevents tumour growth.
    Crombez L; Morris MC; Dufort S; Aldrian-Herrada G; Nguyen Q; Mc Master G; Coll JL; Heitz F; Divita G
    Nucleic Acids Res; 2009 Aug; 37(14):4559-69. PubMed ID: 19483097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A non-covalent peptide-based strategy for protein and peptide nucleic acid transduction.
    Gros E; Deshayes S; Morris MC; Aldrian-Herrada G; Depollier J; Heitz F; Divita G
    Biochim Biophys Acta; 2006 Mar; 1758(3):384-93. PubMed ID: 16545342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved cellular activity of antisense peptide nucleic acids by conjugation to a cationic peptide-lipid (CatLip) domain.
    Koppelhus U; Shiraishi T; Zachar V; Pankratova S; Nielsen PE
    Bioconjug Chem; 2008 Aug; 19(8):1526-34. PubMed ID: 18646838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insight into the role of physicochemical parameters in a novel series of amphipathic peptides for efficient DNA delivery.
    Sharma R; Shivpuri S; Anand A; Kulshreshtha A; Ganguli M
    Mol Pharm; 2013 Jul; 10(7):2588-600. PubMed ID: 23725377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The peptide carrier Pep-1 forms biologically efficient nanoparticle complexes.
    Muñoz-Morris MA; Heitz F; Divita G; Morris MC
    Biochem Biophys Res Commun; 2007 Apr; 355(4):877-82. PubMed ID: 17331466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy.
    Deshayes S; Morris M; Heitz F; Divita G
    Adv Drug Deliv Rev; 2008 Mar; 60(4-5):537-47. PubMed ID: 18037526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cell-penetrating peptides and pegylation on transfection efficiency of polyethylenimine in mouse lungs.
    Nguyen J; Xie X; Neu M; Dumitrascu R; Reul R; Sitterberg J; Bakowsky U; Schermuly R; Fink L; Schmehl T; Gessler T; Seeger W; Kissel T
    J Gene Med; 2008 Nov; 10(11):1236-46. PubMed ID: 18780309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of basic amphipathic peptides for cellular delivery of antisense peptide nucleic acids.
    Maier MA; Esau CC; Siwkowski AM; Wancewicz EV; Albertshofer K; Kinberger GA; Kadaba NS; Watanabe T; Manoharan M; Bennett CF; Griffey RH; Swayze EE
    J Med Chem; 2006 Apr; 49(8):2534-42. PubMed ID: 16610796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High gene delivery in tumor by intratumoral injection of tetraarginine-PEG lipid-coated protamine/DNA.
    Fujita T; Furuhata M; Hattori Y; Kawakami H; Toma K; Maitani Y
    J Control Release; 2008 Jul; 129(2):124-7. PubMed ID: 18513820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delivery of antisense peptide nucleic acids to cells by conjugation with small arginine-rich cell-penetrating peptide (R/W)9.
    Cordier C; Boutimah F; Bourdeloux M; Dupuy F; Met E; Alberti P; Loll F; Chassaing G; Burlina F; Saison-Behmoaras TE
    PLoS One; 2014; 9(8):e104999. PubMed ID: 25127364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vectorization of morpholino oligomers by the (R-Ahx-R)4 peptide allows efficient splicing correction in the absence of endosomolytic agents.
    Abes S; Moulton HM; Clair P; Prevot P; Youngblood DS; Wu RP; Iversen PL; Lebleu B
    J Control Release; 2006 Dec; 116(3):304-13. PubMed ID: 17097177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide-mediated cellular delivery of antisense oligonucleotides and their analogues.
    Gait MJ
    Cell Mol Life Sci; 2003 May; 60(5):844-53. PubMed ID: 12827274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced cellular delivery of cell-penetrating peptide-peptide nucleic acid conjugates by photochemical internalization.
    Shiraishi T; Nielsen PE
    Methods Mol Biol; 2011; 683():391-7. PubMed ID: 21053145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear localization and antisense effect of PNA internalized by ASGP-R-mediated endocytosis with protein/DNA conjugates.
    Ishihara T; Kano A; Obara K; Saito M; Chen X; Park TG; Akaike T; Maruyama A
    J Control Release; 2011 Oct; 155(1):34-9. PubMed ID: 20955741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incorporation of Naked Peptide Nucleic Acids into Liposomes Leads to Fast and Efficient Delivery.
    Avitabile C; Accardo A; Ringhieri P; Morelli G; Saviano M; Montagner G; Fabbri E; Gallerani E; Gambari R; Romanelli A
    Bioconjug Chem; 2015 Aug; 26(8):1533-41. PubMed ID: 26176882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.